Fortis Healthcare has officially launched the Fortis Institute of Genomic Medicine, a groundbreaking center dedicated to leveraging the power of genomic science to revolutionize patient care across India.
Backed by Fortis’ robust clinical ecosystem and Agilus Diagnostics’ extensive national network, the institute brings together a multidisciplinary team of experts—including specialists in molecular hematology, oncology, neurology, pediatrics, pathology, genomics, bioinformatics, and artificial intelligence.
Genomics is rapidly reshaping the landscape of modern medicine, offering new possibilities in personalized care, particularly across specialties like oncology, cardiology, and neurology. Anil Vinayak, Group Chief Operating Officer at Fortis Healthcare, emphasized the significance of this initiative:
“The launch of the Fortis Institute of Genomic Medicine is a strategic move toward our vision of being at the forefront of transformative healthcare. By embedding genomics into our core offerings, we’re enabling personalized, data-driven care that enhances patient outcomes and strengthens our leadership in clinical innovation.”
Dr. Ritu Garg, Chief Innovation and Growth Officer at Fortis, added “We believe the future of medicine lies in precision and personalization. This institute reflects our commitment to integrating cutting-edge science with clinical excellence to deliver measurable impact in patient care. We aim to foster innovation that is scalable, sustainable, and truly transformative.”
Yash Rawat, VP & Facility Director at Fortis Memorial Research Institute, Gurugram, underscored the role of genomic testing in managing chronic and non-communicable diseases “Genomics is revolutionizing our approach to early disease detection, treatment accuracy, and risk assessment. From pediatric cases with unexplained conditions to cancer patients requiring targeted therapies, genomic insights personalize treatment and uncover critical data on inherited risks and drug metabolism.”
Looking ahead, Fortis also plans to launch a Genomics-Informed Health Registry, setting new standards in precision medicine. In addition, the institute will introduce India’s first AI-powered genomic reporting platform—tailored for Indian clinicians and aligned with international best practices from ACMG, AMP, and ASCO. This platform will be compliant, clinically relevant, and seamlessly integrated into everyday medical workflows.
